The DOI matches its Crossref record; 230 of the 230 references it cites were found in a registry or an index.
Protein Oxidation and Lipid Peroxidation in Brain of Subjects with Alzheimer's Disease: Insights into Mechanism of Neurodegeneration from Redox Proteomics
Abstract
Alzheimer's disease (AD), the leading cause of dementia, involves regionalized neuronal death, synaptic loss, and an accumulation of intraneuronal, neurofibrillary tangles and extracellular senile plaques. Although the initiating causes leading to AD are unknown, a number of previous studies reported the role of oxidative stress in AD brain. Postmortem analysis of AD brain showed elevated markers of oxidative stress including protein nitrotyrosine, carbonyls in proteins, lipid oxidation products, and oxidized DNA bases. In this review, we focus our attention on the role of protein oxidation and lipid peroxidation in the pathogenesis of AD. Particular attention is given to the current knowledge about the redox proteomics identification of oxidatively modified proteins in AD brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
[42] Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal
Esterbauer, H., & Cheeseman, K. H. (1990) · Methods in Enzymology · doi:10.1016/0076-6879(90)86134-h · Cited by 3,345
Protein Oxidation in Aging, Disease, and Oxidative Stress
Berlett, B. S., & Stadtman, E. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20313 · Cited by 3,332
Pathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052
Oxidative stress hypothesis in Alzheimer’s disease
Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383
Protein carbonyl groups as biomarkers of oxidative stress
Dalle-Donne, I., Rossi, R., Giustarini, D., Milzani, A., & Colombo, R. (2003) · Clinica Chimica Acta · doi:10.1016/s0009-8981(03)00003-2 · Cited by 2,349
Buée, L., Bussière, T., Buée-Scherrer, V., Delacourte, A., & Hof, P. R. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00019-9 · Cited by 2,015
Free radical-mediated oxidation of free amino acids and amino acid residues in proteins
Stadtman, E. R., & Levine, R. L. (2003) · Amino Acids · doi:10.1007/s00726-003-0011-2 · Cited by 1,962
Oxidative stress in neurodegeneration: Cause or consequence?
Andersen, J. K. (2004) · Nature Medicine · doi:10.1038/nrn1434 · Cited by 1,869
Biochemistry and pathology of radical-mediated protein oxidation
DEAN, R. T., FU, S., STOCKER, R., & DAVIES, M. J. (1997) · Biochemical Journal · doi:10.1042/bj3240001 · Cited by 1,683
Mitochondrial abnormalities in Alzheimer's disease
Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367
Activation of microglial cells by β-amyloid protein and interferon-γ
Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314
The measurement and mechanism of lipid peroxidation in biological systems
Gutteridge, J. M. C., & Halliwell, B. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90206-q · Cited by 1,283
Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239
Oxidative stress and Alzheimer disease
Christen, Y. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.2.621s · Cited by 1,158
Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E., & Ikeda, K. (1991) · Brain Research · doi:10.1016/0006-8993(91)91092-f · Cited by 1,157
Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide
Butterfield, D. A., Drake, J., Pocernich, C., & Castegna, A. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02173-6 · Cited by 1,114
Self-citationApolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions
William Rebeck, G., Reiter, J. S., Strickland, D. K., & Hyman, B. T. (1993) · Neuron · doi:10.1016/0896-6273(93)90070-8 · Cited by 1,107
Mannervik, B., Alin, P., Guthenberg, C., Jensson, H., Tahir, M. K., Warholm, M., & Jörnvall, H. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.21.7202 · Cited by 1,071
Ischiropoulos, H. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0755 · Cited by 1,022
Structural plasticity and memory
Lamprecht, R., & LeDoux, J. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1301 · Cited by 1,010
Sayre, L. M., Zelasko, D. A., Harris, P. L. R., Perry, G., Salomon, R. G., & Smith, M. A. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052092.x · Cited by 1,007
Butterfield, D. A., & Lauderback, C. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00794-3 · Cited by 1,001
Self-citationTargeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum?
Klein, W. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01749-5 · Cited by 989
Protein carbonylation in human diseases
Dalle-Donne, I., Giustarini, D., Colombo, R., Rossi, R., & Milzani, A. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00031-5 · Cited by 961
Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer?s disease
HYND, M. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2004.03.007 · Cited by 938
Arispe, N., Rojas, E., & Pollard, H. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.567 · Cited by 926
Ma, J., Yee, A., Brewer, H. B., Das, S., & Potter, H. (1994) · Nature · doi:10.1038/372092a0 · Cited by 871
Membrane proteins and proteomics: Un amour impossible?
Santoni, V., Molloy, M., & Rabilloud, T. (2000) · Electrophoresis · doi:10.1002/(sici)1522-2683(20000401)21:6<1054::aid-elps1054>3.0.co;2-8 · Cited by 852
Impaired Proteasome Function in Alzheimer's Disease
Keller, J. N., Hanni, K. B., & Markesbery, W. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750436.x · Cited by 848
HUMAN CARBONIC ANHYDRASES AND CARBONIC ANHYDRASE DEFICIENCIES
Sly, W. S., & Hu, P. Y. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.002111 · Cited by 830
β-Amyloid1–42 Binds to α7 Nicotinic Acetylcholine Receptor with High Affinity
Wang, H.-Y., Lee, D. H. S., D'Andrea, M. R., Peterson, P. A., Shank, R. P., & Reitz, A. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5626 · Cited by 822
Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid
Wisniewski, T., & Frangione, B. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90444-c · Cited by 802
Allan Butterfield, D. (2002) · Free Radical Research · doi:10.1080/1071576021000049890 · Cited by 786
Hensley, K., Hall, N., Subramaniam, R., Cole, P., Harris, M., Aksenov, M., Aksenova, M., Gabbita, S. P., Wu, J. F., Carney, J. M., et al. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65052146.x · Cited by 779 · cited 2×
“The oxidative modification of these enzymes likely leads to their inactivation (83, 170).”
BackgroundSelf-citationPraticò, D., Uryu, K., Leight, S., Trojanoswki, J. Q., & Lee, V. M.-Y. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-12-04183.2001 · Cited by 777
Neuron numbers and dendritic extent in normal aging and Alzheimer’s disease
Coleman, P. D., & Flood, D. G. (1987) · Neurobiology of Aging · doi:10.1016/0197-4580(87)90127-8 · Cited by 772
Oxidative stress and nitration in neurodegeneration: Cause, effect, or association?
Ischiropoulos, H., & Beckman, J. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17638 · Cited by 747
Miyata, M., & Smith, J. D. (1996) · Nature Genetics · doi:10.1038/ng0996-55 · Cited by 735
The role of inflammation in Alzheimer’s disease
Tuppo, E. E., & Arias, H. R. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.07.009 · Cited by 734
Tau protein and the neurofibrillary pathology of Alzheimer's disease
Goedert, M. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90078-z · Cited by 716
ALLANBUTTERFIELD, D., CASTEGNA, A., LAUDERBACK, C., & DRAKE, J. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00340-2 · Cited by 715
Markesbery, W. R., & Lovell, M. A. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00009-8 · Cited by 680
Mitochondrial dysfunction in neurodegenerative diseases
Beal, M. F. (1998) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00114-5 · Cited by 607
Praticò, D., Clark, C. M., Liun, F., Lee, V. Y.-M., & Trojanowski, J. Q. (2002) · Archives of Neurology · doi:10.1001/archneur.59.6.972 · Cited by 584
Castegna, A., Aksenov, M., Aksenova, M., Thongboonkerd, V., Klein, J. B., Pierce, W. M., Booze, R., Markesbery, W. R., & Butterfield, D. A. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00914-0 · Cited by 581
Self-citationCastegna, A., Aksenov, M., Thongboonkerd, V., Klein, J. B., Pierce, W. M., Booze, R., Markesbery, W. R., & Butterfield, D. A. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01103.x · Cited by 581
Self-citationChoi, J., Levey, A. I., Weintraub, S. T., Rees, H. D., Gearing, M., Chin, L.-S., & Li, L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314124200 · Cited by 568
Mark, R., Hensley, K., Butterfield, D., & Mattson, M. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-09-06239.1995 · Cited by 558
Self-citationMark, R. J., Pang, Z., Geddes, J. W., Uchida, K., & Mattson, M. P. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-03-01046.1997 · Cited by 551
Pin1-Dependent Prolyl Isomerization Regulates Dephosphorylation of Cdc25C and Tau Proteins
Zhou, X. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00085-x · Cited by 544
Evidence of increased oxidative damage in subjects with mild cognitive impairment
Keller, J. N., Schmitt, F. A., Scheff, S. W., Ding, Q., Chen, Q., Butterfield, D. A., & Markesbery, W. R. (2005) · Neurology · doi:10.1212/01.wnl.0000156156.13641.ba · Cited by 539
Self-citationEvidence for a membrane defect in Alzheimer disease brain.
Nitsch, R. M., Blusztajn, J. K., Pittas, A. G., Slack, B. E., Growdon, J. H., & Wurtman, R. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1671 · Cited by 536
Proteomic identification of nitrated proteins in Alzheimer's disease brain
Castegna, A., Thongboonkerd, V., Klein, J. B., Lynn, B., Markesbery, W. R., & Butterfield, D. A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01786.x · Cited by 535
Self-citationHensley, K., Maidt, M. L., Yu, Z., Sang, H., Markesbery, W. R., & Floyd, R. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08126.1998 · Cited by 507
Protein oxidation in the brain in Alzheimer's disease
Aksenov, M. Y., Aksenova, M. V., Butterfield, D. A., Geddes, J. W., & Markesbery, W. R. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00580-7 · Cited by 503
Self-citationDeficient glutamate tranport is associated with neurodegeneration in Alzheimer's disease
Masliah, E., Hansen, L., Alford, M., Deteresa, R., & Mallory, M. (1996) · Annals of Neurology · doi:10.1002/ana.410400512 · Cited by 476
Selective degradation of oxidatively modified protein substrates by the proteasome
Grune, T., Merker, K., Sandig, G., & Davies, K. J. A. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00809-x · Cited by 475
Rego, A. C., & Oliveira, C. R. (2003) · Neurochemical Research · doi:10.1023/a:1025682611389 · Cited by 472
Lauderback, C. M., Hackett, J. M., Huang, F. F., Keller, J. N., Szweda, L. I., Markesbery, W. R., & Butterfield, D. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00451.x · Cited by 464
Self-citationAcrolein is increased in Alzheimer’s disease brain and is toxic to primary hippocampal cultures
Lovell, M. A., Xie, C., & Markesbery, W. R. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00235-9 · Cited by 450
Montine, T. J., Neely, M. D., Quinn, J. F., Beal, M. F., Markesbery, W. R., Roberts, L. J., & Morrow, J. D. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00807-9 · Cited by 449
Effects of peroxynitrite‐induced protein modifications on tyrosine phosphorylation and degradation
Gow, A. J., Duran, D., Malcolm, S., & Ischiropoulos, H. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00347-x · Cited by 449
Dalle‐Donne, I., Scaloni, A., Giustarini, D., Cavarra, E., Tell, G., Lungarella, G., Colombo, R., Rossi, R., & Milzani, A. (2005) · Mass Spectrometry Reviews · doi:10.1002/mas.20006 · Cited by 448
Regional Membrane Phospholipid Alterations in Alzheimer's Disease
Prasad, M. R., Lovell, M. A., Yatin, M., Dhillon, H., & Markesbery, W. R. (1998) · Neurochemical Research · doi:10.1023/a:1022457605436 · Cited by 439
Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration
Liou, Y.-C., Sun, A., Ryo, A., Zhou, X. Z., Yu, Z.-X., Huang, H.-K., Uchida, T., Bronson, R., Bing, G., Li, X., et al. (2003) · Nature · doi:10.1038/nature01832 · Cited by 435
Strittmatter, W. J., Weisgraber, K. H., Goedert, M., Saunders, A. M., Huang, D., Corder, E. H., Dong, L.-M., Jakes, R., Alberts, M. J., Gilbert, J. R., et al. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1019 · Cited by 433
Manczak, M., Park, B. S., Jung, Y., & Reddy, P. H. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:5:2:147 · Cited by 430
Formation of Isoprostane-like Compounds (Neuroprostanes) in Vivo from Docosahexaenoic Acid
Roberts, L. J., Montine, T. J., Markesbery, W. R., Tapper, A. R., Hardy, P., Chemtob, S., Dettbarn, W. D., & Morrow, J. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13605 · Cited by 418
The role of polyunsaturated fatty acids in restoring the aging neuronal membrane
YEHUDA, S., RABINOVITZ, S., LCARASSO, R., & IMOSTOFSKY, D. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00074-x · Cited by 403
Protein‐Bound Acrolein: A Novel Marker of Oxidative Stress in Alzheimer's Disease
Calingasan, N. Y., Uchida, K., & Gibson, G. E. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720751.x · Cited by 400
Slooter, A. J. C., Cruts, M., Kalmijn, S., Hofman, A., Breteler, M. M. B., Van Broeckhoven, C., & van Duijn, C. M. (1998) · Archives of Neurology · doi:10.1001/archneur.55.7.964 · Cited by 399 · cited 1×
“among others, apolipoprotein E genotype (120, 195), hyper-”
BackgroundMoskovitz, J., Yim, M. B., & Chock, P. B. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2692 · Cited by 396
Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies
Scheff, S. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.08.002 · Cited by 391
Chapter 7 Protein Oxidation Processes in Aging Brain
Butterfield, D. A., & Stadtman, E. R. (1997) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(08)60057-7 · Cited by 390
Self-citationBusciglio, J., Pelsman, A., Wong, C., Pigino, G., Yuan, M., Mori, H., & Yankner, B. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00604-9 · Cited by 387
Butterfield, D. A., Poon, H. F., St. Clair, D., Keller, J. N., Pierce, W. M., Klein, J. B., & Markesbery, W. R. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.11.002 · Cited by 377
Self-citationA panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease
Carrette, O., Demalte, I., Scherl, A., Yalkinoglu, O., Corthals, G., Burkhard, P., Hochstrasser, D. F., & Sanchez, J. (2003) · PROTEOMICS · doi:10.1002/pmic.200300470 · Cited by 374
Drake, J. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00225-7 · Cited by 371
Synaptic and neuritic alterations during the progression of Alzheimer's disease
Masliah, E., Mallory, M., Hansen, L., Richard, D., Alford, M., & Terry, R. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90121-x · Cited by 370
NO-dependent protein nitration: a cell signaling event or an oxidative inflammatory response?
Schopfer, F. (2003) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.10.006 · Cited by 368
Butterfield, D. A. (1997) · Chemical Research in Toxicology · doi:10.1021/tx960130e · Cited by 364
Self-citationIdentification of nitrated proteins in Alzheimer’s disease brain using a redox proteomics approach
Sultana, R., Poon, H. F., Cai, J., Pierce, W. M., Merchant, M., Klein, J. B., Markesbery, W. R., & Butterfield, D. A. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.10.004 · Cited by 364
Self-citationAdvances in Alzheimer's disease
Katzman, R., & Saitoh, T. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.3.2001787 · Cited by 357
Keller, J. N., Mark, R. J., Bruce, A. J., Blanc, E., Rothstein, J. D., Uchida, K., Waeg, G., & Mattson, M. P. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00065-1 · Cited by 357
Oda, T., Wals, P., Osterburg, H. H., Johnson, S. A., Pasinetti, G. M., Morgan, T. E., Rozovsky, I., Stine, W. B., Snyder, S. W., Holzman, T. F., et al. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1080 · Cited by 352
Holtzman, D. M., Pitas, R. E., Kilbridge, J., Nathan, B., Mahley, R. W., Bu, G., & Schwartz, A. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9480 · Cited by 349
Bosetti, F. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00314-1 · Cited by 348
Different Mechanisms of Oxidative Stress and Neurotoxicity for Alzheimer‘s Aβ(1−42) and Aβ(25−35)
Varadarajan, S., Kanski, J., Aksenova, M., Lauderback, C., & Butterfield, D. A. (2001) · Journal of the American Chemical Society · doi:10.1021/ja010452r · Cited by 346
Self-citationAbnormalities of mitochondrial enzymes in Alzheimer disease
Gibson, G. E., Sheu, K.-F. R., & Blass, J. P. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050099 · Cited by 345
Sultana, R., Boyd-Kimball, D., Poon, H. F., Cai, J., Pierce, W. M., Klein, J. B., Merchant, M., Markesbery, W. R., & Butterfield, D. A. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.021 · Cited by 335
Self-citationEvidence that Aβ42 is the real culprit in alzheimer's disease
Younkin, S. G. (1995) · Annals of Neurology · doi:10.1002/ana.410370303 · Cited by 333
Human apolipoprotein E: the Alzheimer's disease connection
Weisgraber, K. H., & Mahley, R. W. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.13.8940294 · Cited by 331
(1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00056-1 · Cited by 330
Self-citation4-Hydroxy-2-nonenal-mediated Impairment of Intracellular Proteolysis during Oxidative Stress
Okada, K., Wangpoengtrakul, C., Osawa, T., Uchida, K., Toyokuni, S., & Tanaka, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.23787 · Cited by 325
Morrow, J. D., Awad, J. A., Kato, T., Takahashi, K., Badr, K. F., Roberts, L. J., & Burk, R. F. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116143 · Cited by 319
Cell cycle markers in the hippocampus in Alzheimer's disease
Nagy, Z., Esiri, M. M., Cato, A.-M., & Smith, A. D. (1997) · Acta Neuropathologica · doi:10.1007/s004010050665 · Cited by 318
Determination of Carbonyl Groups in Oxidized Proteins
Levine, R. L., Wehr, N., Williams, J. A., Stadtman, E. R., & Shacter, E. (2003) · Stress Response · doi:10.1385/1-59259-054-3:15 · Cited by 306
Sample Preparation Methods for Mass Spectrometric Peptide Mapping Directly from 2-DE Gels
Jensen, O. N., Wilm, M., Shevchenko, A., & Mann, M. (2003) · 2-D Proteome Analysis Protocols · doi:10.1385/1-59259-584-7:513 · Cited by 305
Beckers, C. J. M., Block, M. R., Glick, B. S., Rothman, J. E., & Balch, W. E. (1989) · Nature · doi:10.1038/339397a0 · Cited by 291
Akama, K. T., & Van Eldik, L. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.7918 · Cited by 287
Oxidative Modification of Creatine Kinase BB in Alzheimer’s Disease Brain
Aksenov, M., Aksenova, M., Butterfield, D. A., & Markesbery, W. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742520.x · Cited by 286
Self-citationRibosomal RNA in Alzheimer Disease Is Oxidized by Bound Redox-active Iron
Honda, K., Smith, M. A., Zhu, X., Baus, D., Merrick, W. C., Tartakoff, A. M., Hattier, T., Harris, P. L., Siedlak, S. L., Fujioka, H., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500526200 · Cited by 280
Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment
Markesbery, W. R., Kryscio, R. J., Lovell, M. A., & Morrow, J. D. (2005) · Annals of Neurology · doi:10.1002/ana.20629 · Cited by 273
Butterfield, D. A., & Boyd-Kimball, D. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.10.014 · Cited by 267
Self-citationPlanel, E., Miyasaka, T., Launey, T., Chui, D.-H., Tanemura, K., Sato, S., Murayama, O., Ishiguro, K., Tatebayashi, Y., & Takashima, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5561-03.2004 · Cited by 261
Decrease in Peptide Methionine Sulfoxide Reductase in Alzheimer's Disease Brain
Gabbita, S. P., Aksenov, M. Y., Lovell, M. A., & Markesbery, W. R. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731660.x · Cited by 256
Sultana, R., Boyd-Kimball, D., Poon, H. F., Cai, J., Pierce, W. M., Klein, J. B., Markesbery, W. R., Zhou, X. Z., Lu, K. P., & Butterfield, D. A. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.05.005 · Cited by 253
Self-citationAdvances in protein solubilisation for two-dimensional electrophoresis
Herbert, B. (1999) · Electrophoresis · doi:10.1002/(sici)1522-2683(19990101)20:4/5<660::aid-elps660>3.0.co;2-q · Cited by 253
Butterfield, D. A., Reed, T., Perluigi, M., De Marco, C., Coccia, R., Cini, C., & Sultana, R. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.12.017 · Cited by 246
Self-citationIsoprostanes and related products of lipid peroxidation in neurodegenerative diseases
Montine, K. S., Quinn, J. F., Zhang, J., Fessel, J. P., Roberts, L. J., Morrow, J. D., & Montine, T. J. (2004) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2003.10.010 · Cited by 243
Yatin, S. M., Varadarajan, S., & Butterfield, D. A. (2000) · Journal of Alzheimer's Disease · doi:10.3233/jad-2000-2212 · Cited by 239
Self-citationGlucose regulation and cognitive functions: relation to Alzheimer's disease and diabetes
Messier, C., & Gagnon, M. (1996) · Behavioural Brain Research · doi:10.1016/0166-4328(95)00153-0 · Cited by 237
Rebeck, G. W., Harr, S. D., Hyman, B. T., & Strickland, D. K. (1995) · Annals of Neurology · doi:10.1002/ana.410370212 · Cited by 232
Pryor, W. A., & Porter, N. A. (1990) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(90)90153-a · Cited by 230
Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease
Praticò, D., & Sung, S. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6209 · Cited by 229
Fiala, M., Zhang, L., Gan, X.-H., Sherry, B. A., Taub, D. D., Graves, M. C., Hama, S., Way, D., Weinand, M. E., Witte, M. H., et al. (1998) · PubMed Central · Cited by 229
Protein oxidation and 20S proteasome-dependent proteolysis in mammalian cells
Shringarpure, R., Grune, T., & Davies, K. J. A. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000787 · Cited by 222
Limitations of current proteomics technologies
Garbis, S., Lubec, G., & Fountoulakis, M. (2005) · Journal of Chromatography A · doi:10.1016/j.chroma.2005.04.059 · Cited by 220
Nitration of Tau Protein Is Linked to Neurodegeneration in Tauopathies
Horiguchi, T., Uryu, K., Giasson, B. I., Ischiropoulos, H., LightFoot, R., Bellmann, C., Richter-Landsberg, C., Lee, V. M.-Y., & Trojanowski, J. Q. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63462-1 · Cited by 219
Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain
Butterfield, D. A. (2004) · Brain Research · doi:10.1016/j.brainres.2003.12.012 · Cited by 210
Self-citationHamajima, N., Matsuda, K., Sakata, S., Tamaki, N., Sasaki, M., & Nonaka, M. (1996) · Gene · doi:10.1016/s0378-1119(96)00445-3 · Cited by 208
Apolipoprotein E and the CNS Response to Injury
Laskowitz, D. T., Horsburgh, K., & Roses, A. D. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199805000-00001 · Cited by 201
Mechanisms of Cell Signaling and Inflammation in Alzheimers Disease
Ho, G., Drego, R., Hakimian, E., & Masliah, E. (2005) · Current Drug Target -Inflammation & Allergy · doi:10.2174/1568010053586237 · Cited by 199
Increased lipoprotein oxidation in alzheimer’s disease
Schippling, S., Kontush, A., Arlt, S., Buhmann, C., Stürenburg, H.-J., Mann, U., Müller-Thomsen, T., & Beisiegel, U. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00247-6 · Cited by 199
Butterfield, D. A., Hensley, K., Cole, P., Subramaniam, R., Aksenov, M., Aksenova, M., Bummer, P. M., Haley, B. E., & Carney, J. M. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68062451.x · Cited by 191
Self-citationLafon-Cazal, M., Culcasi, M., Gaven, F., Pietri, S., & Bockaert, J. (1993) · Neuropharmacology · doi:10.1016/0028-3908(93)90020-4 · Cited by 189
Arendt, T. (2003) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2003.09.007 · Cited by 188
Schönberger, S. J., Edgar, P. F., Kydd, R. R., Faull, R. L. M., & Cooper, G. J. S. (2001) · PROTEOMICS · doi:10.1002/1615-9861(200111)1:12<1519::aid-prot1519>3.0.co;2-l · Cited by 187
Fiala, M., Zhang, L., Gan, X., Sherry, B., Taub, D., Graves, M. C., Hama, S., Way, D., Weinand, M., Witte, M., et al. (1998) · Molecular Medicine · doi:10.1007/bf03401753 · Cited by 187
Neely, M. D., Sidell, K. R., Graham, D. G., & Montine, T. J. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722323.x · Cited by 186
Dynamics of protein nitration in cells and mitochondria
Aulak, K. S., Koeck, T., Crabb, J. W., & Stuehr, D. J. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00743.2003 · Cited by 186
The Identification and Characterization of Oxidized RNAs in Alzheimer's Disease
Shan, X., Tashiro, H., & Lin, C.-L. G. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-12-04913.2003 · Cited by 185
Pocernich, C. B., Cardin, A. L., Racine, C. L., Lauderback, C. M., & Allan Butterfield, D. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00012-2 · Cited by 183
Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration
Butterfield, D. A., Boyd‐Kimball, D., & Castegna, A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01948.x · Cited by 183
Self-citationRedox proteomics: from protein modifications to cellular dysfunction and disease
Butterfield, D. A., & Dalle‐Donne, I. (2014) · Mass Spectrometry Reviews · doi:10.1002/mas.21404 · Cited by 182
Self-citationWeeber, E. J., Levy, M., Sampson, M. J., Anflous, K., Armstrong, D. L., Brown, S. E., Sweatt, J. D., & Craigen, W. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201649200 · Cited by 181
Genetic dissection of Alzheimer disease, a heterogeneous disorder.
Schellenberg, G. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8552 · Cited by 177
Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease
Zhang, J., Goodlett, D. R., Quinn, J. F., Peskind, E., Kaye, J. A., Zhou, Y., Pan, C., Yi, E., Eng, J., Wang, Q., et al. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7205 · Cited by 176
Hoyer, S. (2004) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-8969-7_8 · Cited by 174
Tohgi, H., Abe, T., Yamazaki, K., Murata, T., Ishizaki, E., & Isobe, C. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00406-1 · Cited by 173
Vitamin E and Neurodegenerative Disorders Associated with Oxidative Stress
Allan Butterfield, D., Castegna, A., Drake, J., Scapagnini, G., & Calabrese, V. (2002) · Nutritional Neuroscience · doi:10.1080/10284150290028954 · Cited by 171
Neuroplasticity in Alzheimer's disease
Teter, B., & Ashford, J. W. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10441 · Cited by 170
Methionine residue 35 is important in amyloid β-peptide-associated free radical oxidative stress
Varadarajan, S., Yatin, S., Kanski, J., Jahanshahi, F., & Butterfield, D. A. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00093-3 · Cited by 169
Self-citationSoluble β-Amyloid Induction of Alzheimer's Phenotype for Human Fibroblast K + Channels
Etcheberrigaray, R., Ito, E., Kim, C. S., & Alkon, D. L. (1994) · Science · doi:10.1126/science.8146663 · Cited by 167
(1995) · PubMed · Cited by 167
Schutkowski, M., Bernhardt, A., Zhou, X. Z., Shen, M., Reimer, U., Rahfeld, J.-U., Lu, K. P., & Fischer, G. (1998) · Biochemistry · doi:10.1021/bi973060z · Cited by 164
Lipid peroxidation in neurodegeneration: new insights into Alzheimerʼs disease
Arlt, S., Beisiegel†, U., & Kontush, A. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200206000-00009 · Cited by 161
Rukhsana Sultana, A., & Butterfield, D. A. (2004) · Neurochemical Research · doi:10.1007/s11064-004-7028-0 · Cited by 153
Self-citationButterfield, D. A., & Kański, J. (2002) · Peptides · doi:10.1016/s0196-9781(02)00066-9 · Cited by 153
Self-citationHistochemical detection of 4-hydroxynonenal protein in Alzheimer amyloid
Ando, Y., Brännström, T., Uchida, K., Nyhlin, N., Näsman, B., Suhr, O. B., Yamashita, T., Olsson, T., Salhy, M. E., Uchino, M., et al. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00042-2 · Cited by 152
Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells
Gómez‐Ramos, A., Díaz‐Nido, J., Smith, M. A., Perry, G. L., & Ávila, J. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10525 · Cited by 152
Lauderback, C. M., Kański, J., Hackett, J. M., Maeda, N., Kindy, M. S., & Butterfield, D. A. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03228-0 · Cited by 149
Self-citationTolar, M., Keller, J. N., Chan, S., Mattson, M. P., Marques, M. A., & Crutcher, K. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-16-07100.1999 · Cited by 148
Smith, M. A., Richey, P. L., Taneda, S., Kutty, R. K., Lm, S., Monnier, V. M., & Perry, G. L. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb21836.x · Cited by 147
Neurochemical enzyme changes in Alzheimer's and Pick's disease
Meier‐Ruge, W., Iwangoff, P., & Reichlmeier, K. (1984) · Archives of Gerontology and Geriatrics · doi:10.1016/0167-4943(84)90007-4 · Cited by 146
Quantitation of apolipoprotein E mRNA in the liver and peripheral tissues of nonhuman primates.
Newman, T. C., Dawson, P. A., Rudel, L. L., & Williams, D. L. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89575-8 · Cited by 144
Evidence for Increased oxidative Damage in Patients with Cystic Fibrosis
Brown, R. K., & Kelly, F. J. (1994) · Pediatric Research · doi:10.1203/00006450-199410000-00013 · Cited by 143
Shringarpure, R., Grune, T., Sitte, N., & Davies*, K. J. A. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000660 · Cited by 140
Lahiri, D. K., Sambamurti, K., & Bennett, D. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.024 · Cited by 138
Lopez, M. F., Mikulskis, A., Kuzdzal, S. A., Bennett, D. A., Kelly, J., Golenko, E. E., DiCesare, J. L., Denoyer, E. R., Patton, W. F., Ediger, R., et al. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.053090 · Cited by 137
Blanc, E. M., Kelly, J. F., Mark, R. J., Waeg, G., & Mattson, M. P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69020570.x · Cited by 136
Protein carbonyl measurement by enzyme-linked immunosorbent assay
Winterbourn, C. C., & Buss, I. H. (1999) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(99)00118-4 · Cited by 134
Volatile anesthetics block actin-based motility in dendritic spines
Kaech, S., Brinkhaus, H., & Matus, A. I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10433 · Cited by 134
Oxidized neprilysin in aging and Alzheimer’s disease brains
Wang, D.-S., Iwata, N., Hama, E., Saido, T. C., & Dickson, D. W. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.003 · Cited by 131
Oxidative Stress: The Old Enemy in Alzheimers Disease Pathophysiology
Moreira, P. I., Honda, K., Liu, Q., Santos, M. S., Oliveira, C. R., Aliev, G., Nunomura, A., Zhu, X., Smith, M. A., & Perry, G. L. (2005) · Current Alzheimer Research · doi:10.2174/156720505774330537 · Cited by 130
Lübec, G., Nonaka, M., Krapfenbauer, K., Gratzer, M., Cairns, N. J., & Fountoulakis, M. (1999) · Springer eBooks · doi:10.1007/978-3-7091-6380-1_10 · Cited by 128
Mitochondria in Alzheimer's disease
Swerdlow, R. H., & Kish, S. J. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)53013-0 · Cited by 126
Poon, H. F., Gururaj Joshi, A., Rukhsana Sultana, A., Farr, S. A., Banks, W. A., Morley, J. E., Calabrese, V., & Butterfield, D. A. (2004) · Brain Research · doi:10.1016/j.brainres.2004.05.048 · Cited by 126
Self-citationLipid Peroxides in the Free Radical Pathophysiology of Brain Diseases
Farooqui, A. A., & Horrocks, L. A. (1998) · Cellular and Molecular Neurobiology · doi:10.1023/a:1020625717298 · Cited by 124
Binding Sites of Amyloid β-Peptide in Cell Plasma Membrane and Implications for Alzheimers Disease
Verdier, Y., & Penke, B. (2004) · Current Protein and Peptide Science · doi:10.2174/1389203043486937 · Cited by 118
Recent advances in the biochemistry and clinical relevance of the isoprostane pathway
Musiek, E. S., Yin, H., Milne, G. L., & Morrow, J. D. (2005) · Lipids · doi:10.1007/s11745-005-1460-7 · Cited by 117
Kurt, M. A., Davies, D. C., Kidd, M., Duff, K., & Howlett, D. R. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00084-6 · Cited by 114
Abdul, H. M., Rukhsana Sultana, A., Keller, J. N., Clair, D. K. S., Markesbery, W. R., & Butterfield, D. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03647.x · Cited by 114
Self-citationAcrolein inhibits NADH-linked mitochondrial enzyme activity: Implications for Alzheimer's disease
Pocernich, C. B., & Butterfield, D. A. (2003) · Neurotoxicity Research · doi:10.1007/bf03033161 · Cited by 111
Self-citationCastegna, A., Lauderback, C. M., Abdul, H. M., & Butterfield, D. A. (2004) · Brain Research · doi:10.1016/j.brainres.2004.01.036 · Cited by 111
Self-citationPedersen, W. A., Cashman, N. R., & Mattson, M. P. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.6890 · Cited by 109
Vitamin E and Other Antioxidants in Neuroprotection
Behl, C. (1999) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831.69.3.213 · Cited by 103
Oxidative modification of proteins in the frontal cortex of Alzheimer's disease brain
Korolainen, M. A., Goldsteins, G., Nyman, T. A., Alafuzoff, I. I., Koıstınaho, J., & Pirttilä, T. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.11.010 · Cited by 102
The Role of Superoxide Dismutation in Malaria Parasites
Schwartz, E., Samuni, A., Friedman, I., Hempelmann, E., & Golenser, J. (1999) · Inflammation · doi:10.1023/a:1020261600498 · Cited by 97
Glycosylation changes in Alzheimer’s disease as revealed by a proteomic approach
Kanninen, K. M., Goldsteins, G., Auriola, S. O. K., Alafuzoff, I. I., & Koıstınaho, J. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.06.013 · Cited by 97
Kański, J., Aksenova, M. V., Schöneich, C., & Butterfield, D. A. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00821-3 · Cited by 94
Self-citationHyun, D., Lee, M., Halliwell, B. B., & Jenner, P. G. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01125.x · Cited by 93
The role of APOE polymorphisms in late-onset dementias
Corder, E. H., Lannfelt, L., Bogdanović, N., Fratiglioni, L., & Mori, H. (1998) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050223 · Cited by 91
Inverse association of Pin1 and tau accumulation in Alzheimer's disease hippocampus
Holzer, M., Gärtner, U., Stöbe, A., Härtig, W., Gruschka, H., Brückner, M. K., & Arendt, T. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0581-1 · Cited by 90
Arispe, N. J., Pollard, H. B., & Rojas, E. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb44414.x · Cited by 89
Debra Boyd-kimball, A., Rukhsana Sultana, A., Abdul, H. M., & Butterfield, D. A. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6509 · Cited by 88
Self-citationPhosphorylation-dependent prolyl isomerization: a novel cell cycle regulatory mechanism
Lu, K. P. (2000) · Springer eBooks · doi:10.1007/978-1-4615-4253-7_8 · Cited by 84
Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies
Ramakrishnan, P., Dickson, D. W., & Davies, P. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00109-8 · Cited by 84
Abdul, H. M., & Butterfield, D. A. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.12.002 · Cited by 82
Self-citationDynamics of lipid peroxidation and its inhibition by antioxidants
Niki, E., Noguchi, N., & Gotoh, N. (1993) · Biochemical Society Transactions · doi:10.1042/bst0210313 · Cited by 82
Generation of α-hydroxyaldehydic compounds in the course of lipid peroxidation
Loidl‐Stahlhofen, A., Hannemann, K., & Spiteller, G. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)90020-5 · Cited by 80
Rukhsana Sultana, A., Marzia Perluigi, A., & Butterfield, D. A. (2005) · Journal of Chromatography B · doi:10.1016/j.jchromb.2005.09.024 · Cited by 80
Self-citationRoses, A. D. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb32598.x · Cited by 78
The Interaction of Amyloid-β with ApoE
Carter, D. B. (2005) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/0-387-23226-5_13 · Cited by 78
Aksenova, M. V., Butterfield, D. A., Zhang, S., Underwood, M. Y., & Geddes, J. W. (2002) · Journal of Neurotrauma · doi:10.1089/08977150252932433 · Cited by 77
Self-citationProteomic Identification of Lower Apolipoprotein A-I in Alzheimer’s Disease
Liu, H., Hu, C., Chang, J., Sung, S., Lee, L.-S., Yuan, R.-Y., & Leu, S. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000090676 · Cited by 76
Role of Phosphorylation in the Conformation of τ Peptides Implicated in Alzheimer's Disease
Daly, N. L., Hoffmann, R., Otvos, L. J., & Craik, D. J. (2000) · Biochemistry · doi:10.1021/bi0004807 · Cited by 75
Howard, B. J., Yatin, S. M., Hensley, K., Allen, K. L., Kelly, J. P., Carney, J. M., & Butterfield, D. A. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67052045.x · Cited by 74
Self-citation
Cited by
Ighodaro, O. M., & Akinloye, O. A. (2018) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2017.09.001 · Cited by 3,939
Maes, M., Galecki, P., Chang, Y. S., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.05.004 · Cited by 1,140
Multi-target-Directed Ligands To Combat Neurodegenerative Diseases
Cavalli, A., Bolognesi, M. L., Minarini, A., Rosini, M., Tumiatti, V., Recanatini, M., & Melchiorre, C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7009364 · Cited by 1,152
Lipid peroxidation: Physiological levels and dual biological effects
Niki, E. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.05.032 · Cited by 1,006
Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans
Marrocco, I., Altieri, F., & Peluso, I. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/6501046 · Cited by 855
Metadata
- Authors
- Sultana, R., Perluigi, M., & Butterfield, D. A.
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2006-11
- Volume
- 8
- Issue
- 11-12
- Pages
- 2021-2037
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- OpenAlex
- W1978308357
- Cited by
- 262
- References
- 230
- FWCI
- 12.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.